Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel platinum compound reported

March 15, 1996

AllerVax codevelopment terminated by HMR

March 15, 1996

AI-502 slated to enter clinical trials

March 15, 1996

Axis Genetics reports on vaccine technology

March 15, 1996

T Cell Sciences, ArQule to collaborate on T cell modulators

March 15, 1996

Colloral dose refinement study underway

March 15, 1996

Lilly reports drugs for osteoarthritis

March 15, 1996

Glaxo Wellcome formalizes development status of arthritis drug

March 15, 1996

U.S. phase III trials of Remune begin

March 15, 1996

Nitazoxanide advances in phase II

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...